PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study

Sponsor
Cook Research Incorporated (Industry)
Overall Status
Completed
CT.gov ID
NCT02571907
Collaborator
(none)
40
28
1
79.1
1.4
0

Study Details

Study Description

Brief Summary

The purpose of this extended study is to evaluate the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in patients in a treatment of aortoiliac and iliac aneurysms.

Condition or Disease Intervention/Treatment Phase
  • Device: Zenith® Branch Endovascular Graft-Iliac Bifurcation,
  • Device: Atrium iCAST™
  • Device: Zenith® Flex AAA Endovascular Graft
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation
Actual Study Start Date :
Apr 1, 2014
Actual Primary Completion Date :
Nov 1, 2015
Actual Study Completion Date :
Nov 4, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Zenith® Branch Endovascular Graft-Iliac Bifurcation

Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the Atrium iCAST™ and the Zenith® Flex AAA Endovascular Graft

Device: Zenith® Branch Endovascular Graft-Iliac Bifurcation,
Implantation of the Zenith® Branch Endovascular Graft-Iliac Bifurcation.
Other Names:
  • Branch Graft
  • Device: Atrium iCAST™
    Implantation of Atrium iCAST

    Device: Zenith® Flex AAA Endovascular Graft
    Implantation of the Zenith Flex Endovascular Graft

    Outcome Measures

    Primary Outcome Measures

    1. Number of patients with freedom from patency-related intervention defined as a secondary intervention to treat a > 60 % stenosis of the internal iliac artery associated with clinical symptoms. [6 months]

    Secondary Outcome Measures

    1. Freedom from morbidity (i.e., morbidity index) [30 days]

      Morbidity index based on a composite endpoint of 31 pre-specified measure elements in seven categories (i.e., cardiovascular, pulmonary, renal, bowel, wound, neurologic, and vascular).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • An aortioiliac or iliac aneurysm

    • An unsuitable distal sealing site for a traditional Zenith iliac leg graft within the common lilac artery

    Exclusion Criteria:
    • Less than 18 years of age

    • Inability or refusal to give informed consent

    • Disease considerations that would compromise patient safety or study outcomes

    • Pregnant, breast-feeding or planning on becoming pregnant prior to completion of the study

    • Unwilling or unable to comply with the follow-up schedule

    • Simultaneously participating in another investigative device or drug study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mayo Foundation for Medical Education and Research Phoenix Arizona United States 85054
    2 VA Palo Alto HCS Palo Alto California United States 94304
    3 Stanford University Medical School Stanford California United States 94305
    4 Christine E. Lynn Heart and Vascular Institute Boca Raton Florida United States 33431
    5 South Florida Medical Imaging Fort Lauderdale Florida United States 33308
    6 University of Florida Gainesville Florida United States 32610
    7 Emory University Hospital Atlanta Georgia United States 30322
    8 St. Anthony's Medical Center Rockford Illinois United States 61108
    9 Methodist Hospital of Indiana Indianapolis Indiana United States 46202
    10 University of Kentucky Hospital Lexington Kentucky United States 40536
    11 University of Massachusetts Worcester Massachusetts United States 01655
    12 William Beaumont Hospital Royal Oak Michigan United States 48073
    13 Mayo Clinic Rochester Minnesota United States 55905
    14 Washington University School of Medicine Saint Louis Missouri United States 63110
    15 Mercy Hospital East Communities Saint Louis Missouri United States 63141
    16 University of Nebraska Omaha Nebraska United States 68105
    17 Dartmouth Hitchcock Medical Center Lebanon New Hampshire United States 03756
    18 Columbia University Medical Center New York New York United States 10032
    19 Weill Cornell Medical Center New York New York United States 10065
    20 University of North Carolina Chapel Hill North Carolina United States 27599
    21 Cleveland Clinic Foundation Cleveland Ohio United States 44195
    22 Hospital of the University of Pennsylvania Philadelphia Pennsylvania United States 19104
    23 Allegheny General Hospital Pittsburgh Pennsylvania United States 15212
    24 University of Pittsburgh Medical Center Pittsburgh Pennsylvania United States 15213
    25 Medical University of South Carolina Charleston South Carolina United States 29425
    26 UT Southwestern Dallas Texas United States 75235
    27 University of Virginia Charlottesville Virginia United States 22908
    28 Aurora St. Luke's Hospital Milwaukee Wisconsin United States 53215

    Sponsors and Collaborators

    • Cook Research Incorporated

    Investigators

    • Principal Investigator: W. Anthony Lee, MD FACS, Christine E. Lynn Heart and Vascular Institute

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Cook Research Incorporated
    ClinicalTrials.gov Identifier:
    NCT02571907
    Other Study ID Numbers:
    • 05-625 P2
    First Posted:
    Oct 8, 2015
    Last Update Posted:
    Jun 28, 2021
    Last Verified:
    Jun 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Keywords provided by Cook Research Incorporated
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 28, 2021